title: Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium.
abstract: The expression and activation of serine/threonine protein kinase, Akt, in leiomyoma and in adjacent myometrium of human uteri was studied parallel with the changes of Bcl-2, Bax proteins, estrogen and progesterone receptors during menstrual cycle and early stage of the menopause. Abundant expression of Akt protein was detected in the studied tissues during menstrual cycle, the rate of increase was higher in leiomyoma than in corresponding myometrium. The expression of estrogen receptor alpha, progesterone receptor and of Bcl-2 protein changed parallel with that of Akt protein. The level of phosphorylated Akt (pAkt(473)) was seen only in leiomyoma samples from the growing period of tumors. At early stage of menopause levels of all studied proteins were lower than that in the menstrual cycle with the exception of Bax protein expression, which was high in leiomyoma. Our data suggest the involvement of phosphatidylinositol 3-kinase/Akt signaling in the pathomechanism of leiomyoma.
authors.affiliation: Department of Obstetrics and Gynecology, Pécs University Medical School, Edesanyák u.13/15, H-7624 Pécs, Hungary. kalman.kovacs@aok.pte.hu
authors.forename: Kálmán A
authors.initials: KA
authors.lastname: Kovács
authors.forename: Ferenc
authors.initials: F
authors.lastname: Lengyel
authors.forename: József L
authors.initials: JL
authors.lastname: Környei
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Vértes
authors.forename: István
authors.initials: I
authors.lastname: Szabó
authors.forename: Balázs
authors.initials: B
authors.lastname: Sümegi
authors.forename: Marietta
authors.initials: M
authors.lastname: Vértes
mesh_terms: D000328:Adult; D015153:Blotting, Western; D004789:Enzyme Activation; D047628:Estrogen Receptor alpha; D005260:Female; D005498:Follicular Phase / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D007889:Leiomyoma / Q000378:metabolism*; D008183:Luteal Phase / Q000378:metabolism; D008593:Menopause / Q000378:metabolism; D008875:Middle Aged; D009215:Myometrium / Q000378:metabolism*; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis* / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis*; D011960:Receptors, Estrogen / Q000032:analysis / Q000096:biosynthesis; D011980:Receptors, Progesterone / Q000032:analysis / Q000096:biosynthesis; D015398:Signal Transduction; D051028:bcl-2-Associated X Protein
chemical_list: C494826:BAX protein, human; D047628:Estrogen Receptor alpha; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D051028:bcl-2-Associated X Protein; C494918:AKT1 protein, human; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt